News
Increased interest for AcouTrap EV isolation for nano flow cytometry applications
Over the past months, AcouSort has experienced an increased interest in extracellular vesicle (EV) isolation and sample preparation for...
Read MoreAcouSort restructures its North American sales operation
AcouSort and the Company’s Sales Director North America Kelley Intehar have mutually agreed to terminate their collaboration. The reason...
Read MoreKallelse till årsstämma i AcouSort AB (publ)
RegulatoryAktieägarna i AcouSort AB (publ), 556824–1037, kallas härmed till årsstämma Tisdagen den 30 april 2024 kl. 09.00 på Medicon...
Read MoreIncreased interest for AcouTrap EV isolation for nano flow cytometry applications
Over the past months, AcouSort has experienced an increased interest in extracellular vesicle (EV) isolation and sample preparation for...
Read MoreAcouSort restructures its North American sales operation
AcouSort and the Company’s Sales Director North America Kelley Intehar have mutually agreed to terminate their collaboration. The reason...
Read MoreKallelse till årsstämma i AcouSort AB (publ)
RegulatoryAktieägarna i AcouSort AB (publ), 556824–1037, kallas härmed till årsstämma Tisdagen den 30 april 2024 kl. 09.00 på Medicon...
Read MoreAcouSort presents at RedEye Regenerative medicine/ Cell Therapy event
AcouSort’s CEO Torsten Freltoft presents at RedEye Regenerative medicine/ Cell Therapy event in Stockholm February 14 2024. Follow the...
Read MoreAcouSort presents at BioStock Life Science Summit October 26
Read more: https://www.biostock.se/biostock-life-science-fall-summit-2023/.
Read MoreCEO Torsten Freltoft presents AcouSort’s opportunities in cell therapy and diagnostics at LSX Nordic Congress on October 10
AcouSort is an innovative medical technology company developing critical components for instrumentation used in the diagnostics, analytics, and cell...
Read More